Sonora Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$11K Hold
3,000
﹤0.01% 767
2021
Q2
$13K Hold
3,000
﹤0.01% 676
2021
Q1
$12K Hold
3,000
﹤0.01% 1169
2020
Q4
$12K Hold
3,000
﹤0.01% 1120
2020
Q3
$8K Hold
3,000
﹤0.01% 1309
2020
Q2
$8K Hold
3,000
﹤0.01% 1203
2020
Q1
$7K Hold
3,000
﹤0.01% 1184
2019
Q4
$14K Buy
+3,000
New +$12.3K ﹤0.01% 1029
2019
Q3
Sell
-3,000
Closed -$10K 1838
2019
Q2
$10K Hold
3,000
﹤0.01% 1184
2019
Q1
$9K Hold
3,000
﹤0.01% 1105
2018
Q4
$8K Hold
3,000
﹤0.01% 933
2018
Q3
$10K Hold
3,000
﹤0.01% 883
2018
Q2
$8K Hold
3,000
﹤0.01% 888
2018
Q1
$6.6K Hold
3,000
﹤0.01% 899
2017
Q4
$5.97K Buy
+3,000
New +$6.53K ﹤0.01% 919
2017
Q3
Sell
-3,000
Closed -$9.66K 1233
2017
Q2
$9.66K Hold
3,000
﹤0.01% 739
2017
Q1
$8.52K Hold
3,000
﹤0.01% 722
2016
Q4
$6.99K Hold
3,000
﹤0.01% 663
2016
Q3
$5.04K Hold
3,000
﹤0.01% 688
2016
Q2
$3.15K Hold
3,000
﹤0.01% 744
2016
Q1
$3.03K Hold
3,000
﹤0.01% 803
2015
Q4
$4K Hold
3,000
﹤0.01% 675
2015
Q3
$5K Buy
+3,000
New +$5.88K ﹤0.01% 761

Other funds holding ATRS

Sonora Investment Management's ATRS Position: Q3 2021 in Review

Sonora Investment Management held its Antares Pharma, Inc. (ATRS) position steady in Q3 2021 at 3,000 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Sonora Investment Management first reported a position in ATRS in Q3 2015 and has held it in 23 quarters since. The position peaked at $14K in Q4 2019. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

  • Sonora Investment Management held 3,000 shares of Antares Pharma, Inc. worth $11K as of Q3 2021.
  • Sonora Investment Management left its Antares Pharma, Inc. share count unchanged in Q3 2021.
  • Antares Pharma, Inc. made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #767 holding.
  • Sonora Investment Management first reported a position in Antares Pharma, Inc. in Q3 2015 and has held it in 23 quarters since.
  • Sonora Investment Management's Antares Pharma, Inc. position peaked at $14K in Q4 2019.
  • 170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.